Protopic and Skin chapped - a phase IV clinical study of FDA data
Summary:
We study 6,165 people who take Protopic (tacrolimus) or have Skin chapped. No report of Skin chapped is found in people who take Protopic.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Protopic?
Protopic has active ingredients of tacrolimus. It is often used in eczema. eHealthMe is studying from 5,403 Protopic users. Check the latest studies of Protopic.
What is Skin Chapped?
Skin chapped is found to be associated with 86 drugs and 218 conditions by eHealthMe. Check the latest studies of Skin chapped.
No report is found.
Do you take Protopic and have Skin chapped?
- Check whether Skin chapped is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Protopic:
- Protopic (5,403 reports)
Skin chapped treatments and more:
- Skin chapped (762 reports)
How severe was Skin chapped and when was it recovered:
Expand to all the drugs that have ingredients of tacrolimus:
Browse all side effects of Protopic:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Skin chapped:
Browse all the conditions that are associated with Skin chapped:
How the study uses the data?
The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Protopic) and Protopic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Latuda and Movement - Uncontrolled Or Slow for Men aged 20-29 - now
- Latuda and Slow Involuntary Movements Of Large Muscle Groups for Men aged 20-29 - a second ago
- Latuda and Leg And Arm Movements - Uncontrollable for Men aged 20-29 - a second ago
- Latuda and Involuntary Slow And Twisting Movements for Men aged 20-29 - a second ago
- Latuda and Choreoathetosis for Men aged 20-29 - a second ago
- Latuda and Athetoid Movements for Men aged 20-29 - 2 seconds ago
- Latuda and Arm And Leg Movements - Uncontrollable for Men aged 20-29 - 2 seconds ago
- Latuda and Dystonia for Men aged 20-29 - 2 seconds ago
- Sucralfate and Kyphosis for Men aged 60+ - 4 seconds ago
- Sucralfate and Scheuermann'S Disease for Men aged 60+ - 4 seconds ago